Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

9.19
Delayed Data
As of Oct 18
 +0.29 / +3.26%
Today’s Change
5.82
Today|||52-Week Range
9.71
+18.73%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close8.90
Today’s open8.98
Day’s range8.82 - 9.37
Volume151,371
Average volume (3 months)106,600
Market cap$301.7M
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+16.15%
Earnings growth (this year)+21.65%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales3.43
Price/Book5.04

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...-0.04-1.33%
OXFDOxford Immunotec Glo...-0.08-0.49%
QTNTQuotient Ltd+0.17+3.88%
TRIBTrinity Biotech PLC-0.01-0.19%
Data as of 3:59pm ET, 10/18/2017

Financials

Next reporting dateNovember 27, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$65.1M
Annual profit (last year)-$31.4M
Net profit margin-48.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Bonnie H. Anderson
President &
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts